Literature DB >> 33402735

Plant genome editing branches out.

Logan T Hille1,2,3, Benjamin P Kleinstiver4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33402735      PMCID： PMC9113649          DOI： 10.1038/s41477-020-00840-7

Source DB:  PubMed          Journal:  Nat Plants        ISSN： 2055-0278            Impact factor:   17.352


× No keyword cloud information.
  10 in total

Review 1.  Applications of CRISPR-Cas in agriculture and plant biotechnology.

Authors:  Haocheng Zhu; Chao Li; Caixia Gao
Journal:  Nat Rev Mol Cell Biol       Date:  2020-09-24       Impact factor: 94.444

2.  PAM-less plant genome editing using a CRISPR-SpRY toolbox.

Authors:  Qiurong Ren; Simon Sretenovic; Shishi Liu; Xu Tang; Lan Huang; Yao He; Li Liu; Yachong Guo; Zhaohui Zhong; Guanqing Liu; Yanhao Cheng; Xuelian Zheng; Changtian Pan; Desuo Yin; Yingxiao Zhang; Wanfeng Li; Liwang Qi; Chenghao Li; Yiping Qi; Yong Zhang
Journal:  Nat Plants       Date:  2021-01-04       Impact factor: 15.793

3.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

4.  Engineered CRISPR-Cas9 nuclease with expanded targeting space.

Authors:  Hiroshi Nishimasu; Xi Shi; Soh Ishiguro; Linyi Gao; Seiichi Hirano; Sae Okazaki; Taichi Noda; Omar O Abudayyeh; Jonathan S Gootenberg; Hideto Mori; Seiya Oura; Benjamin Holmes; Mamoru Tanaka; Motoaki Seki; Hisato Hirano; Hiroyuki Aburatani; Ryuichiro Ishitani; Masahito Ikawa; Nozomu Yachie; Feng Zhang; Osamu Nureki
Journal:  Science       Date:  2018-08-30       Impact factor: 47.728

5.  Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.

Authors:  Russell T Walton; Kathleen A Christie; Madelynn N Whittaker; Benjamin P Kleinstiver
Journal:  Science       Date:  2020-03-26       Impact factor: 47.728

Review 6.  Base editing: advances and therapeutic opportunities.

Authors:  Elizabeth M Porto; Alexis C Komor; Ian M Slaymaker; Gene W Yeo
Journal:  Nat Rev Drug Discov       Date:  2020-10-19       Impact factor: 112.288

7.  Engineered CRISPR-Cas9 nucleases with altered PAM specificities.

Authors:  Benjamin P Kleinstiver; Michelle S Prew; Shengdar Q Tsai; Ved V Topkar; Nhu T Nguyen; Zongli Zheng; Andrew P W Gonzales; Zhuyun Li; Randall T Peterson; Jing-Ruey Joanna Yeh; Martin J Aryee; J Keith Joung
Journal:  Nature       Date:  2015-06-22       Impact factor: 49.962

8.  Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition.

Authors:  Edze R Westra; Ekaterina Semenova; Kirill A Datsenko; Ryan N Jackson; Blake Wiedenheft; Konstantin Severinov; Stan J J Brouns
Journal:  PLoS Genet       Date:  2013-09-05       Impact factor: 5.917

9.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

10.  Continuous evolution of SpCas9 variants compatible with non-G PAMs.

Authors:  Shannon M Miller; Tina Wang; Peyton B Randolph; Mandana Arbab; Max W Shen; Tony P Huang; Zaneta Matuszek; Gregory A Newby; Holly A Rees; David R Liu
Journal:  Nat Biotechnol       Date:  2020-02-10       Impact factor: 54.908
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.